These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 25522898)
41. The most recent advances in pathophysiology and management of tumour necrosis factor receptor-associated periodic syndrome (TRAPS): personal experience and literature review. Magnotti F; Vitale A; Rigante D; Lucherini OM; Cimaz R; Muscari I; Granados Afonso de Faria A; Frediani B; Galeazzi M; Cantarini L Clin Exp Rheumatol; 2013; 31(3 Suppl 77):141-9. PubMed ID: 23899820 [TBL] [Abstract][Full Text] [Related]
42. First Case of TNF-Receptor-Associated Autoinflammatory Syndrome (TRAPS) in Bulgaria. Solakov PT Folia Med (Plovdiv); 2016 Sep; 58(3):211-214. PubMed ID: 27760004 [TBL] [Abstract][Full Text] [Related]
43. Tumor necrosis factor inhibitors in tumor necrosis factor receptor-associated periodic syndrome: still a chance to work? Rigante D Intern Emerg Med; 2017 Mar; 12(2):269-270. PubMed ID: 27817124 [No Abstract] [Full Text] [Related]
44. Dramatic etanercept-induced remission of relapsing febrile sciatic neuralgia related to p46l mutation of the tnfrsf1a gene. Serratrice J; de Roux-Serratrice C; Disdier P; Dodé C; Weiller PJ Clin Rheumatol; 2007 Sep; 26(9):1535-6. PubMed ID: 16941196 [TBL] [Abstract][Full Text] [Related]
45. Somatic mosaicism in adult-onset TNF receptor-associated periodic syndrome (TRAPS). Kontzias A; Zarabi SK; Calabrese C; Wang Y; Judis L; Yao Q; Cheng YW Mol Genet Genomic Med; 2019 Aug; 7(8):e791. PubMed ID: 31397119 [TBL] [Abstract][Full Text] [Related]
46. Mutant tumor necrosis factor receptor associated with tumor necrosis factor receptor-associated periodic syndrome is altered antigenically and is retained within patients' leukocytes. Todd I; Radford PM; Daffa N; Bainbridge SE; Powell RJ; Tighe PJ Arthritis Rheum; 2007 Aug; 56(8):2765-73. PubMed ID: 17665435 [TBL] [Abstract][Full Text] [Related]
47. Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: a low-penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa. Stojanov S; Lohse P; Lohse P; Hoffmann F; Renner ED; Zellerer S; Kéry A; Shin YS; Haas D; Hoffmann GF; Belohradsky BH Arthritis Rheum; 2004 Jun; 50(6):1951-8. PubMed ID: 15188372 [TBL] [Abstract][Full Text] [Related]
48. Tumour necrosis factor receptor-associated periodic syndrome (TRAPS): state of the art and future perspectives. Cantarini L; Lucherini OM; Muscari I; Frediani B; Galeazzi M; Brizi MG; Simonini G; Cimaz R Autoimmun Rev; 2012 Nov; 12(1):38-43. PubMed ID: 22884554 [TBL] [Abstract][Full Text] [Related]
50. Multiple sclerosis and the TNFRSF1A R92Q mutation: clinical characteristics of 21 cases. Kümpfel T; Hoffmann LA; Pellkofer H; Pöllmann W; Feneberg W; Hohlfeld R; Lohse P Neurology; 2008 Nov; 71(22):1812-20. PubMed ID: 19029521 [TBL] [Abstract][Full Text] [Related]
51. [Progress in classification and treatment for TNF receptor-associated periodic syndrome]. Tsukamoto H; Ueda N; Horiuchi T Nihon Rinsho Meneki Gakkai Kaishi; 2011; 34(5):361-8. PubMed ID: 22041423 [TBL] [Abstract][Full Text] [Related]
52. A monoallelic double mutation as a cause for TNF receptor-associated periodic fever syndrome. Trübenbach J; Wildhardt G; Niebel J; Hawle H; Steinberger D Rheumatol Int; 2010 Apr; 30(6):805-9. PubMed ID: 19547977 [TBL] [Abstract][Full Text] [Related]
53. Genetic profiling of autoinflammatory disorders in patients with periodic fever: a prospective study. De Pieri C; Vuch J; De Martino E; Bianco AM; Ronfani L; Athanasakis E; Bortot B; Crovella S; Taddio A; Severini GM; Tommasini A Pediatr Rheumatol Online J; 2015; 13():11. PubMed ID: 25866490 [TBL] [Abstract][Full Text] [Related]
54. Differential cytokine secretion results from p65 and c-Rel NF-κB subunit signaling in peripheral blood mononuclear cells of TNF receptor-associated periodic syndrome patients. Nedjai B; Hitman GA; Church LD; Minden K; Whiteford ML; McKee S; Stjernberg S; Pettersson T; Ranki A; Hawkins PN; Arkwright PD; McDermott MF; Turner MD Cell Immunol; 2011; 268(2):55-9. PubMed ID: 21420073 [TBL] [Abstract][Full Text] [Related]
55. Severe TNF receptor-associated periodic syndrome due to 2 TNFRSF1A mutations including a new F60V substitution. Haas SL; Lohse P; Schmitt WH; Hildenbrand R; Karaorman M; Singer MV; Böcker U Gastroenterology; 2006 Jan; 130(1):172-8. PubMed ID: 16401480 [TBL] [Abstract][Full Text] [Related]
56. Clinical and functional characterisation of a novel TNFRSF1A c.605T>A/V173D cleavage site mutation associated with tumour necrosis factor receptor-associated periodic fever syndrome (TRAPS), cardiovascular complications and excellent response to etanercept treatment. Stojanov S; Dejaco C; Lohse P; Huss K; Duftner C; Belohradsky BH; Herold M; Schirmer M Ann Rheum Dis; 2008 Sep; 67(9):1292-8. PubMed ID: 18180277 [TBL] [Abstract][Full Text] [Related]
57. The diagnostic evaluation of patients with potential adult-onset autoinflammatory disorders: our experience and review of the literature. Muscari I; Iacoponi F; Cantarini L; Lucherini OM; Simonini G; Brizi MG; Vitale A; Frediani B; Cimaz R; Galeazzi M Autoimmun Rev; 2012 Nov; 12(1):10-3. PubMed ID: 22878268 [TBL] [Abstract][Full Text] [Related]
58. Successful treatment of a patient with tumor necrosis factor receptor-associated periodic syndrome using a half-dose of etanercept. Kusuhara K; Hoshina T; Saito M; Ishimura M; Inoue H; Horiuchi T; Sato T; Hara T Pediatr Int; 2012 Aug; 54(4):552-5. PubMed ID: 22830546 [TBL] [Abstract][Full Text] [Related]